SEVs derived from endothelial cells contained high levels of Angiopoietin-like protein 2 (ANGPTL2) protein, which binds to the leukocyte immunoglobulin-like receptor B2 (LILRB2 receptor) and accelerates leukemia progression[134]. Here, ANGPTL2 is linked to leukemia.